Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 23andMe Holding Co. ME

Consumer Cyclical Healthcare Advertising Agencies
23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including... see more

Recent & Breaking News (NDAQ:ME)

ME SHAREHOLDER NOTICE: BFA Law Reminds 23andMe Holding Co. Investors to Contact the Firm about Ongoing Investigation to the Company's Board of Directors

Newsfile September 24, 2024

MEI INVESTOR ALERT: Methode Electronics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Accesswire September 23, 2024

ME SHAREHOLDER ALERT: 23andMe Stockholders are Reminded to Contact BFA Law about Continuing Investigation into the Company for Breaches of Fiduciary Duties (Nasdaq:ME)

Accesswire September 23, 2024

Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.

Accesswire September 23, 2024

ME STOCK ALERT: 23andMe Holding Co. Shareholders are Encouraged to Contact BFA Law About Investigation into the Company's Board of Directors

Newsfile September 22, 2024

ME INVESTIGATION ALERT: 23andMe Holding Co. Shareholders are Alerted to Contact BFA Law regarding Ongoing Investigation into the Company (Nasdaq:ME)

Accesswire September 20, 2024

ME INVESTOR NEWS: BFA Law Notifies 23andMe Holding Co. Investors that Lost Money to Contact the Firm about Investigation for Breaches of Fiduciary Duties

Newsfile September 20, 2024

ME STOCK NOTICE: An Investigation has been Initiated Against 23andMe Holding Co. for Breaches of Fiduciary Duties - Shareholders are Urged to Contact BFA Law

Accesswire September 19, 2024

Independent Directors of 23andMe Resign from Board

GlobeNewswire September 17, 2024

23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study

GlobeNewswire September 15, 2024

23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial

GlobeNewswire September 15, 2024

One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations

GlobeNewswire September 12, 2024

23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024

GlobeNewswire September 3, 2024

Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program

GlobeNewswire August 28, 2024

23andMe Data Breach - Hackers Targeted Jewish and Chinese Users Data

Accesswire August 15, 2024

23andMe Data Breach - Hackers Targeted Jewish and Chinese Users Data

Accesswire August 14, 2024

23andMe Holding Co (NASDAQ: ME) Jewish and Chinese Users

Accesswire August 13, 2024

Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach

Accesswire August 12, 2024

DATA BREACH - 23andMe Jewish & Chinese Consumers May be Affected

Accesswire August 9, 2024

23andMe Reports First Quarter Fiscal 2025 Financial Results

GlobeNewswire August 8, 2024